Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicenter prospective dose-ranging randomized trial - Schiele,F.; Lindgaerde,F.; Eriksson,H.; for the International Multicenter Hirudin Study group,null. (Thromb Haemost, 1997)